APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brucellosis Vaccines

Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.

Selected research

Market Structure

Global Brucellosis Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025194 pages

Choose your research edition.

Industry ResearchBrucellosis Vaccines Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Brucellosis Vaccines Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Brucellosis Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brucellosis Vaccines Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Brucellosis Vaccines Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.

Global Brucellosis Vaccines main players are Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, etc. Global top four manufacturers hold a share above 35%. China is the largest market, with a share about 30%.

This report provides an overview of the global Brucellosis Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Brucellosis Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Brucellosis Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Brucellosis Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Brucellosis Vaccines Segment by Company

Jinyu

Colorado Serum

Boehringer Ingelheim

Biogenesis-Bago

Vetal Company

CZ Veterinaria

SYVA Laboratorios

Indian Immunologicals

Qilu

Tecnovax

Hester Biosciences

Zoetis

Onderstepoort Biological

Instituto Rosenbusch

Ceva Sante Animale

Calier & Biologicos Laverlam

Biovet

Brucellosis Vaccines Segment by Type

S19 Vaccine

RB51 Vaccine Strain

Brucellosis Vaccines Segment by Application

Cattle

Sheep

Others

Brucellosis Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucellosis Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brucellosis Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucellosis Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Brucellosis Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Brucellosis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Brucellosis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Brucellosis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Brucellosis Vaccines Industry Trends Table 2. Brucellosis Vaccines Industry Drivers Table 3. Brucellosis Vaccines Industry Opportunities and Challenges Table 4. Brucellosis Vaccines Industry Restraints Table 5. Global Brucellosis Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Brucellosis Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Brucellosis Vaccines Sales by Manufacturers (M Doses) & (2021-2026) Table 8. Global Brucellosis Vaccines Sales Market Share by Manufacturers Table 9. Global Brucellosis Vaccines Average Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 10. Global Brucellosis Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Brucellosis Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Brucellosis Vaccines Manufacturers, Product Type & Application Table 13. Global Brucellosis Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Brucellosis Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of S19 Vaccine Table 17. Major Manufacturers of RB51 Vaccine Strain Table 18. Global Brucellosis Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 19. Global Brucellosis Vaccines Sales by Type (2021-2026) & (M Doses) Table 20. Global Brucellosis Vaccines Sales by Type (2027-2032) & (M Doses) Table 21. Global Brucellosis Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Brucellosis Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Brucellosis Vaccines Revenue by Type 2021 VS 2025 VS 2032 (M Doses) Table 24. Global Brucellosis Vaccines Revenue by Type (2021-2026) & (M Doses) Table 25. Global Brucellosis Vaccines Revenue by Type (2027-2032) & (M Doses) Table 26. Global Brucellosis Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Brucellosis Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cattle Table 29. Major Manufacturers of Sheep Table 30. Major Manufacturers of Others Table 31. Global Brucellosis Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 32. Global Brucellosis Vaccines Sales by Application (2021-2026) & (M Doses) Table 33. Global Brucellosis Vaccines Sales by Application (2027-2032) & (M Doses) Table 34. Global Brucellosis Vaccines Sales Market Share by Application (2021-2026) Table 35. Global Brucellosis Vaccines Sales Market Share by Application (2027-2032) Table 36. Global Brucellosis Vaccines Revenue by Application 2021 VS 2025 VS 2032 (M Doses) Table 37. Global Brucellosis Vaccines Revenue by Application (2021-2026) & (M Doses) Table 38. Global Brucellosis Vaccines Revenue by Application (2027-2032) & (M Doses) Table 39. Global Brucellosis Vaccines Revenue Market Share by Application (2021-2026) Table 40. Global Brucellosis Vaccines Revenue Market Share by Application (2027-2032) Table 41. Global Brucellosis Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 42. Global Brucellosis Vaccines Sales by Region (2021-2026) & (M Doses) Table 43. Global Brucellosis Vaccines Sales Market Share by Region (2021-2026) Table 44. Global Brucellosis Vaccines Sales Forecasted by Region (2027-2032) & (M Doses) Table 45. Global Brucellosis Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Brucellosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 47. North America Brucellosis Vaccines Sales by Country (2021-2026) & (M Doses) Table 48. North America Brucellosis Vaccines Sales by Country (2027-2032) & (M Doses) Table 49. Europe Brucellosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 50. Europe Brucellosis Vaccines Sales by Country (2021-2026) & (M Doses) Table 51. Europe Brucellosis Vaccines Sales by Country (2027-2032) & (M Doses) Table 52. Asia Pacific Brucellosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 53. Asia Pacific Brucellosis Vaccines Sales by Country (2021-2026) & (M Doses) Table 54. Asia Pacific Brucellosis Vaccines Sales by Country (2027-2032) & (M Doses) Table 55. South America, Middle East and Africa Brucellosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 56. South America, Middle East and Africa Brucellosis Vaccines Sales by Country (2021-2026) & (M Doses) Table 57. South America, Middle East and Africa Brucellosis Vaccines Sales by Country (2027-2032) & (M Doses) Table 58. Global Brucellosis Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Brucellosis Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Brucellosis Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Brucellosis Vaccines Revenue Market Share by Region (2021-2026) Table 62. Global Brucellosis Vaccines Revenue Market Share by Region (2027-2032) Table 63. Jinyu Company Information Table 64. Jinyu Business Overview Table 65. Jinyu Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Jinyu Brucellosis Vaccines Product Portfolio Table 67. Jinyu Recent Development Table 68. Colorado Serum Company Information Table 69. Colorado Serum Business Overview Table 70. Colorado Serum Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Colorado Serum Brucellosis Vaccines Product Portfolio Table 72. Colorado Serum Recent Development Table 73. Boehringer Ingelheim Company Information Table 74. Boehringer Ingelheim Business Overview Table 75. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Boehringer Ingelheim Brucellosis Vaccines Product Portfolio Table 77. Boehringer Ingelheim Recent Development Table 78. Biogenesis-Bago Company Information Table 79. Biogenesis-Bago Business Overview Table 80. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Biogenesis-Bago Brucellosis Vaccines Product Portfolio Table 82. Biogenesis-Bago Recent Development Table 83. Vetal Company Company Information Table 84. Vetal Company Business Overview Table 85. Vetal Company Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Vetal Company Brucellosis Vaccines Product Portfolio Table 87. Vetal Company Recent Development Table 88. CZ Veterinaria Company Information Table 89. CZ Veterinaria Business Overview Table 90. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. CZ Veterinaria Brucellosis Vaccines Product Portfolio Table 92. CZ Veterinaria Recent Development Table 93. SYVA Laboratorios Company Information Table 94. SYVA Laboratorios Business Overview Table 95. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. SYVA Laboratorios Brucellosis Vaccines Product Portfolio Table 97. SYVA Laboratorios Recent Development Table 98. Indian Immunologicals Company Information Table 99. Indian Immunologicals Business Overview Table 100. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Indian Immunologicals Brucellosis Vaccines Product Portfolio Table 102. Indian Immunologicals Recent Development Table 103. Qilu Company Information Table 104. Qilu Business Overview Table 105. Qilu Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Qilu Brucellosis Vaccines Product Portfolio Table 107. Qilu Recent Development Table 108. Tecnovax Company Information Table 109. Tecnovax Business Overview Table 110. Tecnovax Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Tecnovax Brucellosis Vaccines Product Portfolio Table 112. Tecnovax Recent Development Table 113. Hester Biosciences Company Information Table 114. Hester Biosciences Business Overview Table 115. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Hester Biosciences Brucellosis Vaccines Product Portfolio Table 117. Hester Biosciences Recent Development Table 118. Zoetis Company Information Table 119. Zoetis Business Overview Table 120. Zoetis Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Zoetis Brucellosis Vaccines Product Portfolio Table 122. Zoetis Recent Development Table 123. Onderstepoort Biological Company Information Table 124. Onderstepoort Biological Business Overview Table 125. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Onderstepoort Biological Brucellosis Vaccines Product Portfolio Table 127. Onderstepoort Biological Recent Development Table 128. Instituto Rosenbusch Company Information Table 129. Instituto Rosenbusch Business Overview Table 130. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Instituto Rosenbusch Brucellosis Vaccines Product Portfolio Table 132. Instituto Rosenbusch Recent Development Table 133. Ceva Sante Animale Company Information Table 134. Ceva Sante Animale Business Overview Table 135. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Ceva Sante Animale Brucellosis Vaccines Product Portfolio Table 137. Ceva Sante Animale Recent Development Table 138. Calier & Biologicos Laverlam Company Information Table 139. Calier & Biologicos Laverlam Business Overview Table 140. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio Table 142. Calier & Biologicos Laverlam Recent Development Table 143. Biovet Company Information Table 144. Biovet Business Overview Table 145. Biovet Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Biovet Brucellosis Vaccines Product Portfolio Table 147. Biovet Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Brucellosis Vaccines Distributors List Table 151. Brucellosis Vaccines Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Brucellosis Vaccines Product Image Figure 2. Global Brucellosis Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brucellosis Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Brucellosis Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global Brucellosis Vaccines Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Top 5 and 10 Brucellosis Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. S19 Vaccine Image Figure 9. RB51 Vaccine Strain Image Figure 10. Global Brucellosis Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 11. Global Brucellosis Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Brucellosis Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Brucellosis Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 14. Global Brucellosis Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Brucellosis Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Cattle Image Figure 17. Sheep Image Figure 18. Others Image Figure 19. Global Brucellosis Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 20. Global Brucellosis Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Brucellosis Vaccines Sales Market Share by Application (2021-2032) Figure 22. Global Brucellosis Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 23. Global Brucellosis Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Brucellosis Vaccines Revenue Market Share by Application (2021-2032) Figure 25. North America Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 26. North America Brucellosis Vaccines Sales Market Share by Country (2021-2032) Figure 27. U.S. Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 28. Canada Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 29. Mexico Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 30. Europe Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 31. Europe Brucellosis Vaccines Sales Market Share by Country (2021-2032) Figure 32. Germany Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 33. France Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 34. U.K. Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 35. Italy Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 36. Netherlands Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 37. Asia Pacific Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 38. Asia Pacific Brucellosis Vaccines Sales Market Share by Country (2021-2032) Figure 39. China Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 40. Japan Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 41. South Korea Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 42. Southeast Asia Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 43. India Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 44. Australia Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 45. South America, Middle East and Africa Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 46. South America, Middle East and Africa Brucellosis Vaccines Sales Market Share by Country (2021-2032) Figure 47. Brazil Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 48. South Africa Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 49. Saudi Arabia Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 50. Turkey Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 51. Argentina Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 52. UAE Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 53. Egypt Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 54. Chile Brucellosis Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 55. Global Brucellosis Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Brucellosis Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Figure 58. North America Brucellosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. Europe Brucellosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Brucellosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Brucellosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Brucellosis Vaccines Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Brucellosis Vaccines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • S19 Vaccine
  • RB51 Vaccine Strain
Applications
  • Cattle
  • Sheep
  • Others
Companies covered
  • Jinyu
  • Colorado Serum
  • Boehringer Ingelheim
  • Biogenesis-Bago
  • Vetal Company
  • CZ Veterinaria
  • SYVA Laboratorios
  • Indian Immunologicals
  • Qilu
  • Tecnovax
  • Hester Biosciences
  • Zoetis
  • Onderstepoort Biological
  • Instituto Rosenbusch
  • Ceva Sante Animale
  • Calier & Biologicos Laverlam
  • Biovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Brucellosis Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Brucellosis Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Brucellosis Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Brucellosis Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Brucellosis Vaccines Market Dynamics
  1. 2.1 Brucellosis Vaccines Industry Trends
  2. 2.2 Brucellosis Vaccines Industry Drivers
  3. 2.3 Brucellosis Vaccines Industry Opportunities and Challenges
  4. 2.4 Brucellosis Vaccines Industry Restraints
3 Brucellosis Vaccines Market by Manufacturers
  1. 3.1 Global Brucellosis Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Brucellosis Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Brucellosis Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Brucellosis Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Brucellosis Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Brucellosis Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Brucellosis Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Brucellosis Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Brucellosis Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Brucellosis Vaccines Tier 1, Tier 2, and Tier 3
4 Brucellosis Vaccines Market by Type
  1. 4.1 Brucellosis Vaccines Type Introduction
  2. 4.1.1 S19 Vaccine
  3. 4.1.2 RB51 Vaccine Strain
  4. 4.2 Global Brucellosis Vaccines Sales by Type
  5. 4.2.1 Global Brucellosis Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Brucellosis Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Brucellosis Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Brucellosis Vaccines Revenue by Type
  9. 4.3.1 Global Brucellosis Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Brucellosis Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Brucellosis Vaccines Revenue Market Share by Type (2021-2032)
5 Brucellosis Vaccines Market by Application
  1. 5.1 Brucellosis Vaccines Application Introduction
  2. 5.1.1 Cattle
  3. 5.1.2 Sheep
  4. 5.1.3 Others
  5. 5.2 Global Brucellosis Vaccines Sales by Application
  6. 5.2.1 Global Brucellosis Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Brucellosis Vaccines Sales by Application (2021-2032)
  8. 5.2.3 Global Brucellosis Vaccines Sales Market Share by Application (2021-2032)
  9. 5.3 Global Brucellosis Vaccines Revenue by Application
  10. 5.3.1 Global Brucellosis Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Brucellosis Vaccines Revenue by Application (2021-2032)
  12. 5.3.3 Global Brucellosis Vaccines Revenue Market Share by Application (2021-2032)
6 Global Brucellosis Vaccines Sales by Region
  1. 6.1 Global Brucellosis Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Brucellosis Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Brucellosis Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Brucellosis Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Brucellosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Brucellosis Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Brucellosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Brucellosis Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Brucellosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Brucellosis Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Brucellosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Brucellosis Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Brucellosis Vaccines Revenue by Region
  1. 7.1 Global Brucellosis Vaccines Revenue by Region
  2. 7.1.1 Global Brucellosis Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Brucellosis Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Brucellosis Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Brucellosis Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Brucellosis Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Brucellosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Brucellosis Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Brucellosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Brucellosis Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Brucellosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Brucellosis Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Brucellosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Jinyu
  2. 8.1.1 Jinyu Company Information
  3. 8.1.2 Jinyu Business Overview
  4. 8.1.3 Jinyu Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Jinyu Brucellosis Vaccines Product Portfolio
  6. 8.1.5 Jinyu Recent Developments
  7. 8.2 Colorado Serum
  8. 8.2.1 Colorado Serum Company Information
  9. 8.2.2 Colorado Serum Business Overview
  10. 8.2.3 Colorado Serum Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Colorado Serum Brucellosis Vaccines Product Portfolio
  12. 8.2.5 Colorado Serum Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Brucellosis Vaccines Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Biogenesis-Bago
  20. 8.4.1 Biogenesis-Bago Company Information
  21. 8.4.2 Biogenesis-Bago Business Overview
  22. 8.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biogenesis-Bago Brucellosis Vaccines Product Portfolio
  24. 8.4.5 Biogenesis-Bago Recent Developments
  25. 8.5 Vetal Company
  26. 8.5.1 Vetal Company Company Information
  27. 8.5.2 Vetal Company Business Overview
  28. 8.5.3 Vetal Company Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vetal Company Brucellosis Vaccines Product Portfolio
  30. 8.5.5 Vetal Company Recent Developments
  31. 8.6 CZ Veterinaria
  32. 8.6.1 CZ Veterinaria Company Information
  33. 8.6.2 CZ Veterinaria Business Overview
  34. 8.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CZ Veterinaria Brucellosis Vaccines Product Portfolio
  36. 8.6.5 CZ Veterinaria Recent Developments
  37. 8.7 SYVA Laboratorios
  38. 8.7.1 SYVA Laboratorios Company Information
  39. 8.7.2 SYVA Laboratorios Business Overview
  40. 8.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SYVA Laboratorios Brucellosis Vaccines Product Portfolio
  42. 8.7.5 SYVA Laboratorios Recent Developments
  43. 8.8 Indian Immunologicals
  44. 8.8.1 Indian Immunologicals Company Information
  45. 8.8.2 Indian Immunologicals Business Overview
  46. 8.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Indian Immunologicals Brucellosis Vaccines Product Portfolio
  48. 8.8.5 Indian Immunologicals Recent Developments
  49. 8.9 Qilu
  50. 8.9.1 Qilu Company Information
  51. 8.9.2 Qilu Business Overview
  52. 8.9.3 Qilu Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Qilu Brucellosis Vaccines Product Portfolio
  54. 8.9.5 Qilu Recent Developments
  55. 8.10 Tecnovax
  56. 8.10.1 Tecnovax Company Information
  57. 8.10.2 Tecnovax Business Overview
  58. 8.10.3 Tecnovax Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Tecnovax Brucellosis Vaccines Product Portfolio
  60. 8.10.5 Tecnovax Recent Developments
  61. 8.11 Hester Biosciences
  62. 8.11.1 Hester Biosciences Company Information
  63. 8.11.2 Hester Biosciences Business Overview
  64. 8.11.3 Hester Biosciences Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hester Biosciences Brucellosis Vaccines Product Portfolio
  66. 8.11.5 Hester Biosciences Recent Developments
  67. 8.12 Zoetis
  68. 8.12.1 Zoetis Company Information
  69. 8.12.2 Zoetis Business Overview
  70. 8.12.3 Zoetis Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Zoetis Brucellosis Vaccines Product Portfolio
  72. 8.12.5 Zoetis Recent Developments
  73. 8.13 Onderstepoort Biological
  74. 8.13.1 Onderstepoort Biological Company Information
  75. 8.13.2 Onderstepoort Biological Business Overview
  76. 8.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Onderstepoort Biological Brucellosis Vaccines Product Portfolio
  78. 8.13.5 Onderstepoort Biological Recent Developments
  79. 8.14 Instituto Rosenbusch
  80. 8.14.1 Instituto Rosenbusch Company Information
  81. 8.14.2 Instituto Rosenbusch Business Overview
  82. 8.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Instituto Rosenbusch Brucellosis Vaccines Product Portfolio
  84. 8.14.5 Instituto Rosenbusch Recent Developments
  85. 8.15 Ceva Sante Animale
  86. 8.15.1 Ceva Sante Animale Company Information
  87. 8.15.2 Ceva Sante Animale Business Overview
  88. 8.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ceva Sante Animale Brucellosis Vaccines Product Portfolio
  90. 8.15.5 Ceva Sante Animale Recent Developments
  91. 8.16 Calier & Biologicos Laverlam
  92. 8.16.1 Calier & Biologicos Laverlam Company Information
  93. 8.16.2 Calier & Biologicos Laverlam Business Overview
  94. 8.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio
  96. 8.16.5 Calier & Biologicos Laverlam Recent Developments
  97. 8.17 Biovet
  98. 8.17.1 Biovet Company Information
  99. 8.17.2 Biovet Business Overview
  100. 8.17.3 Biovet Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Biovet Brucellosis Vaccines Product Portfolio
  102. 8.17.5 Biovet Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Brucellosis Vaccines Value Chain Analysis
  2. 9.1.1 Brucellosis Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Brucellosis Vaccines Production Mode & Process
  6. 9.2 Brucellosis Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Brucellosis Vaccines Distributors
  9. 9.2.3 Brucellosis Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst